{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:38:14Z","timestamp":1769499494476,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.coph.2012.12.001","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T00:43:02Z","timestamp":1357260182000},"page":"192-199","source":"Crossref","is-referenced-by-count":31,"title":["Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management"],"prefix":"10.1016","volume":"13","author":[{"given":"Sudarshan","family":"Balla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maen B","family":"Nusair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin A","family":"Alpert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2012.12.001_bib0005","series-title":"URSDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-stage Renal Disease in the United States","author":"US Renal Data System","year":"2011"},{"key":"10.1016\/j.coph.2012.12.001_bib0010","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.ajkd.2006.05.021","article-title":"Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease","volume":"48","author":"Weiner","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.coph.2012.12.001_bib0015","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"Suppl.","key":"10.1016\/j.coph.2012.12.001_bib0190","first-page":"4201","article-title":"Cardiovascular risk factors in pre-dialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) Study","volume":"54","author":"Wheeler","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.coph.2012.12.001_sbref0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Shiffrin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2012.12.001_bib0030","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1523-1755.2005.00551.x","article-title":"Cardiovascular risk factors in chronic kidney disease","volume":"68","author":"Menon","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.coph.2012.12.001_bib0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ahj.2008.02.024","article-title":"Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality","volume":"156","author":"McCullough","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.coph.2012.12.001_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c4986","article-title":"Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population-based cohort study","author":"Di Angelantonio","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.coph.2012.12.001_bib0045","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrcardio.2009.121","article-title":"Cardiovascular risk factor in chronic kidney disease","volume":"6","author":"Van der Zee","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.coph.2012.12.001_bib0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/ncpneph0954","article-title":"Non-traditional risk factors for cardiovascular disease in patients with chronic kidney disease","volume":"4","author":"Kendrick","year":"2008","journal-title":"Nat Clin Pract"},{"key":"10.1016\/j.coph.2012.12.001_sbref0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.2004080656","article-title":"Traditional and non-traditional risk factors predicts coronary heart disease is chronic kidney disease: results from the Atherosclerosis Risk in Communities Study","volume":"16","author":"Muntner","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coph.2012.12.001_bib0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2012.06.017","article-title":"Albuminuria, estimated GFR, traditional risk factors and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular End stage Disease) Study","volume":"60","author":"Smink","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.coph.2012.12.001_sbref0065","first-page":"2014","article-title":"Kidney disease as a risk factor for the development of cardiovascular disease","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2012.12.001_bib0070","first-page":"138","article-title":"Renal parenchymal disease and hypertension","volume":"15","author":"Preston","year":"1998","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.coph.2012.12.001_bib0075","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehi880","article-title":"Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular mortality in middle-aged men and women from the general population","volume":"27","author":"Meisinger","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2012.12.001_bib0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-140-1-200401060-00006","article-title":"The prevalence of non-traditional risk factors for coronary heart disease in patients with chronic kidney disease","volume":"140","author":"Muntner","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coph.2012.12.001_bib0085","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized, controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2012.12.001_bib0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000337082","article-title":"Chronic inflammation and coronary atherosclerosis in patients with end-stage renal disease","volume":"2","author":"Nusair","year":"2012","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.coph.2012.12.001_bib0095","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risks in the chronic kidney disease patient: how do new pieces fit into the puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.coph.2012.12.001_bib0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MOL.0b013e32832dd832","article-title":"Dyslipidemia of kidney disease","volume":"20","author":"Attman","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.coph.2012.12.001_bib0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2012.12.001_bib0110","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2012.12.001_bib0115","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease, study of heart and renal protection: a randomized placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2012.12.001_bib0120","first-page":"970","article-title":"Endothelial dysfunction and chronic kidney disease: treatment options","volume":"9","author":"Wu-wong","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"issue":"Suppl. 84","key":"10.1016\/j.coph.2012.12.001_bib0125","first-page":"550","article-title":"Endothelium-dependent vasodilatation and oxidative stress in chronic renal failures","volume":"64","author":"Annak","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.coph.2012.12.001_bib0130","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1523-1755.2005.00239.x","article-title":"Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors","volume":"67","author":"Barreto","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.coph.2012.12.001_bib0135","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrcardio.2010.115","article-title":"Regulatory mechanisms in vascular calcification","volume":"7","author":"Sage","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.coph.2012.12.001_bib0140","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross sectional study","volume":"361","author":"Ketteler","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2012.12.001_bib0145","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1681\/ASN.2008060572","article-title":"Fetuin-A protects against atherosclerotic calcification in CKD","volume":"20","author":"Westenfeld","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coph.2012.12.001_bib0150","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/319432","article-title":"Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system","author":"Park","year":"2012","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.coph.2012.12.001_bib0155","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shilpak","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2012.12.001_bib0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000324916","article-title":"Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease","volume":"3","author":"Kanbay","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.coph.2012.12.001_bib0165","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bone.2012.02.634","article-title":"Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis","volume":"50","author":"Nakano","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.coph.2012.12.001_bib0170","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population contorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2012.12.001_sbref0175","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high risk population cohorts","volume":"79","author":"van der Velde","year":"2011","journal-title":"Kidney Int"},{"issue":"Suppl. 94","key":"10.1016\/j.coph.2012.12.001_bib0180","first-page":"825","article-title":"Chronic renal failure. A cardiovascular risk factor","volume":"68","author":"Fort","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.coph.2012.12.001_bib0185","first-page":"281","article-title":"Cardiovascular disease in patients with chronic kidney disease. A clinical review","volume":"59","author":"Kaisar","year":"2007","journal-title":"Minerva Urol Nephrol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489212002305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489212002305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T19:01:17Z","timestamp":1539975677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489212002305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1471489212002305"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2012.12.001","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}